PT  - JOURNAL ARTICLE
AU  - Abd El-Raheem, Ghada Omer Hamad
AU  - Awad Yousif, Maysoun Ahmed
AU  - Ibrahim Mohamed, Doaa Salih
TI  - Prediction of COVID-19 mortality among hospitalized patients in Sudan
AID  - 10.1101/2021.03.09.21253179
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.09.21253179
4099  - http://medrxiv.org/content/early/2021/03/11/2021.03.09.21253179.short
4100  - http://medrxiv.org/content/early/2021/03/11/2021.03.09.21253179.full
AB  - Background COVID-19 was primarily reported in China. The mortality rate across countries had ranged from 1% up to more than 10% and it is underestimated in some countries. Advanced age is the most frequently reported factor associated to mortality. Other factors were the presence of comorbidities such as diabetes mellitus, hypertension and obesity. Several models for mortality prediction had been developed to assist in improving the prognosis. The aim of our study was to assess the factors related to mortality among COVID-19 patients and develop a prediction model based on these factors.Methods A retrospective cohort study assessed the factors related to the mortality among COVID-19 patients who attended Imperial Hospital isolation centre on November-December, 2020, Khartoum, Sudan. Statistical tests performed were chi-square test, odds ratio and regression to develop the prediction model. Tests were considered statistically significant when p < 0.05.Results 105 patients were studied. 29% of the patients were deceased, while, 71% were discharged alive. A statistically significant association was found between the age and severity with regards to mortality rate (p=0.034, 0.018 respectively). The model equation for mortality prediction: Mortality = −14.724+ (1.387* Age) + (−0.323* Gender) + (1.814* Admission) + (0.193* Ischemic Heart Disease) + (−0.369* Fever) + (1.595* Cough) + (1.953* Complications) + (0.149* Duration of hospitalization) + (0.999* Enoxaparin dose).Conclusions Age, admission ward, cough and enoxaparin dose were statistically significant predictors for COVID-19 mortality (p= 0.014, 0.011, 0.015, 0.006 respectively).Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was applied for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained from the Medical administration of Imperial Hospital. The study proposal was submitted to the research administration at the State Ministry Of Health (MOH), Khartoum. Expedited review was conducted by the IRB of the MOH and approval was granted. Another copy of the proposal was submitted to the Administration of Private Medical Facilities. Regarding participants, the data were collected retrospectively from medical records and their confidentiality was assured with the use of an anonymous research tool. Informed consents from the patients/ surrogate decision makers were obtained by contacting them through their registered phone numbers. The collected data were used strictly for the purpose of the study objectives. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll supporting data are available.AKIAcute Kidney InjuryDMDiabetes MellitusGIGastro-IntestinalHTNHypertensionICUIntensive Care UnitMOHMinistry Of HealthIHDIschemic Heart DiseaseIRBInstitutional Review BoardOCHAOffice for the Coordination of Humanitarian Affairs